Researchers have recently published a new report in Biological Psychiatry as the first patient in Canada to be treated in the trial has shown...
Research
Behind the research: Testing, teamwork and busy days for COVID-19 scientist
Dr. Rob Kozak, a scientist and clinical microbiologist, has been involved in COVID-19 research since the virus emerged in Canada. In February, Dr...
Dr. Samira Mubareka: a leading expert in Sunnybrook’s response to COVID-19
Infectious disease physician and microbiologist Dr. Samira Mubareka is a member of a local working group of scientists who are researching COVID-19...
Behind the Research: Why so many surveys?
Our research teams use surveys to see how you are doing on your treatment path, what your life is like at home during and after treatments, and more.
Obsessive-compulsive disorder and focused ultrasound
In a North American first, focused ultrasound (FUS) is being studied in a trial for treatment-resistant OCD. Although researchers are still in the...
Behind the research: Study looks at fighting Alzheimer’s disease in a new way
In the first preclinical study of its kind, researchers used focused ultrasound to deliver a treatment deep inside the brain to help boost the health...
Exploring focused ultrasound to enhance drug delivery to breast cancer that spread to the brain
In a new trial, Sunnybrook researchers are exploring the use of focused ultrasound (FUS) to open the blood-brain barrier (BBB) and enhance the...
Behind the research: Ground-breaking trial for treatment of severe alcohol use disorder
One year after Sunnybrook was the first in North Americian hospital to begin a clinical trial investigating the use of deep brain stimulation (DBS)...
Study examines how sleep may help brain immune cells stay “young”
The study – which has been published in the journal Sciences Advances – shows that older adults who sleep poorly have premature aging and abnormal...
Behind the Research: symptom burden in patients with neuroendocrine tumours
In a recent study published in The Oncologist, Dr. Julie Hallet and her colleagues found that many patients facing neuroendocrine tumours (NETs)...